Discover comprehensive details about Ixazomib, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The updated prescription ...

Prasad: I'm back -- new abstract, again talking to Aaron Goodman, Manni Mohyuddin. Ixazomib plus len/dex [lenalidomide/dexamethasone] versus len/dex maintenance after ...

Ixazomib, also known as MLN9708, met its primary endpoint of improving progression-free survival at an interim analysis of a phase 3 trial of relapsed or refractory multiple myeloma. The ...

Author(s)Kumar SK, Buadi FK, LaPlant B, et al. Phase 1/2 trial of ixazomib, cyclophosphamide, dexamethasone in patients with previously untreated symptomatic multiple myeloma. Blood Cancer J. 2018, ...

Researchers sought to determine whether doublet therapy with dexamethasone and ixazomib would improve survival in patients with multiple myeloma compared with pomalidomide. The following article ...

Please provide your email address to receive an email when new articles are posted on . The addition of ixazomib to lenalidomide and dexamethasone did not significantly extend PFS among ...

The 68-year-old patient had multiple myeloma and breast cancer. A new case report details a complete pathological response to a 3-month combination therapy of ixazomib, bendamustine, and dexamethasone ...

Ixazomib is available in a capsule form that should be taken by mouth at least 1 hour before or 2 hours after food. Ixazomib capsule should not be crushed, chewed, or opened but swallowed as a whole ...

The appraisal committee considered evidence submitted by Takeda, a review of this submission by the evidence review group (ERG), and responses from stakeholders. See the committee papers for full ...

Toward Improving Patients’ Experiences of Acute Toxicity From Breast Radiotherapy: Insights From the Analysis of Patient-Reported Outcomes in a Large Multicenter Cohort The December 1, 2020, article ...